tiprankstipranks
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market
4552
JCR Pharmaceuticals Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4552 full AI Analyst Report?

JCR Pharmaceuticals Co., Ltd. (4552) Stock News & Sentiment

1 Followers
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
Premium
Company Announcements
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
2M ago
4552
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
Premium
Company Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
3M ago
4552
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
Premium
Company Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
3M ago
4552
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
Premium
Company Announcements
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
3M ago
4552
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
Premium
Company Announcements
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
3M ago
4552
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
Premium
Company Announcements
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
3M ago
4552
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
Premium
Company Announcements
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
4M ago
4552
More JP:4552 News >

4552 News on the Web

JCR Pharmaceuticals Co., Ltd. (4552) was upgraded to a Buy Rating at Jefferies
TipRanks News
Bullish
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
TipRanks News
Bullish
Citi Sticks to Their Hold Rating for JCR Pharmaceuticals Co., Ltd. (4552)
TipRanks News
Bearish
Jefferies Sticks to Their Hold Rating for JCR Pharmaceuticals Co., Ltd. (4552)
TipRanks News
Bearish
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
TipRanks News
Bullish
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
TipRanks News
Neutral
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
TipRanks News
Neutral
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
JP:4552
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4552’s Media Buzz Sentiment?
Currently, no data Available
What is JP:4552’s weekly average amount of articles?
Currently, no data Available
What is JP:4552’s News Sentiment?
100% of articles about JP:4552 were positive this week, compared to its sector average of 70%.
    Healthcare Stocks that are Trending in the News
    TVTXTravere Therapeutics
    HVOOpen Orphan Plc
    PBMPsyence Biomedical
    QDELQuidelOrtho
    Showing the stocks with the most bullish news sentiment over the past week